Chronic Kidney Disease News

Leflunomide is non-inferior to azathioprine in terms of safety and efficacy for lupus nephritis maintenance therapy, according to data published in the Annals of the Rheumatic Diseases.

Use of patient navigators in chronic kidney disease and kidney failure correlate with improved outcomes in some settings and patient populations, according to data published in Kidney Medicine.

Compared with men, women are at a higher risk of all-cause mortality in the first 5 years following dialysis initiation, according to data published in the American Journal of Kidney Diseases.

Recent data has revealed a growing divide between rheumatologists and nephrologists in their therapeutic choices for patients with lupus nephritis, according to researchers from Spherix Global Insights.

According to data published in Kidney Medicine, patients on dialysis are at a significantly higher risk for hospitalization if they are infected with COVID-19.

Difelikefalin treatment reduced itching intensity among patients with chronic kidney disease-associated pruritus, according to data published in Kidney Medicine.

Black adults showed a higher prevalence for gout than white adults during a 10-year period, even after adjusting for diet, social determinants of health and chronic kidney disease, according to data published in JAMA Network.

Among patients with a high risk for chronic kidney disease progression, less than half attend a nephrology visit within 1 year of established risk, according to a recently published study.

Although percent changes in age-standardized chronic kidney disease are worse for women in 66% of countries included in this study, exceptions exist in which men experience a less favorable change.

Merck announced its investigational factor XI inhibitor to reduce risk for major thrombotic CV events in patients with end-stage renal disease has received fast track designation from the FDA.